Generate Biomedicines, Inc. (GENB) short interest & options flow
NASDAQGENB has shed 11% in a single week, falling to $12.25, yet retail attention has hit a three-month high and the stock sits on the edge of a potential index addition, two forces pulling hard in opposite directions. The most striking data point this week is not the price drop but the attention it has generated. ORTEX's Wikipedia-based retail attention signal has surged to a z-score of…
GENB short interest surges 58% in one week to 3.16M shares, now at 43.1 ORTEX short score following positive analyst revisions.
- Market cap
- $1.61B
- Next earnings
- 5 Feb 2027
Key data as of 14 Nov 2026
Latest signals on GENB
- Short Interest
GENB short interest surges 58% in one week to 3.16M shares, now at 43.1 ORTEX short score following positive analyst revisions.
GENB news and analysis
RSSNo long-form analysis yet for GENB. Pulse alerts and the live data picture are available on ORTEX.
Open GENB on ORTEX →Want the live picture for GENB?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for GENB — free to start on ORTEX.
Sign up for free →Open GENB on ORTEX